 




<DOCTITLE>Availability of Exclusive Licensing of U.S. Patent of a Hyperproducing Cellulase Microoganism</DOCTITLE>



<AGENCY>
AGENCY: 

U.S. Army Aviation and Troop Command, DOD.



</AGENCY>
<ACTION>
ACTION: 

Notice.






</ACTION>
<SUMMARY>
SUMMARY: 

In accordance with 37 CFR 404.7(a)(1), announcement is made of prospective exclusive licenses of a hyperproducing
cellulase microorganism, Patent Number 4,472,504, issued September 19, 1984.



</SUMMARY>
<ADDRESS>
ADDRESSES: 

U.S. Aviation and Troop Command, ATTN: AMSATCJGP, 4300 Goodfellow Blvd., St. Louis, MO 631201798.



</ADDRESS>
<DATE>
DATES: 

Written objections must be filed on or before September 19, 1994.



</DATE>
<FURTHER>
FOR FURTHER INFORMATION CONTACT:



Mr. John L. Lamming, Patent Counsel, telephone: (314) 2639150.



</FURTHER>
<SUPPLEM>
SUPPLEMENTARY INFORMATION: 

The hyperproducing cellulase microorganism was invented by Mr. Benedict J. Gallo (U.S. Patent 4,472,504, issued
September 19, 1984). Rights to this invention are owned by the U.S. Government as represented by the U.S. Army Natick
Research, Development and Engineering Center (Natick RDE Center). Under the authority of section 11(a)(2)
of the Federal Technology Transfer Act of 1986 (Pub. L. 92502) and section 207 of title 35, U.S. Code, the Department
of the Army as represented by Natick RDE Center intends to grant an exclusive license on the hyperproducing cellulase
microorganism to Solvay Enzymes, Inc., P.O. Box 4859, 1003 Industrial Parkway, Elkhart, Indiana 45616. 




Pursuant to 37 CFR 404.(a)(1), any interested party may file written objections to this prospective exclusive license
arrangements. Written objections should be directed to the above address.


</SUPPLEM>
<SIGNER>
Kenneth L. Denton,


</SIGNER>
<SIGNJOB>
Army Federal Register Liaison Officer.


</SIGNJOB>
<FRFILING>
[FR Doc. 9417575 Filed 71994; 8:45 am]


</FRFILING>
<BILLING>
BILLING CODE 371008M
</BILLING>


